Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Clinical Follow-up to Evaluate the Safety of Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.

NCT06790368 is registered in ClinicalTrials.gov with Inmunotek S.L. as lead sponsor.

NCT NCT06790368
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06790368 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Clinical Follow-up to Evaluate the Safety of Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.
Lead sponsor
Inmunotek S.L.
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2025
Completion date
June 1, 2026
Enrollment
80 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

allergy insect stinging, allergy, insect venom, insect sting allergy